Navigation Links
Pfizer contributes critical data to URMC drug safety initiative
Date:1/12/2009

Pfizer Inc. has agreed to provide the University of Rochester Medical Center (URMC) with a unique set of electrocardiographic data that will help researchers develop new methods to ensure the safety of experimental drugs. This is the first time a major pharmaceutical company has agreed to publicly share anonymous data from one of its drug safety trials, including data from the drug that was being evaluated.

Pfizer Global Research and Development's Sandwich Laboratory in the United Kingdom is releasing a large set of continuous electrocardiographic (ECG) recordings to URMC from which more than 1.5 million individual ECGs datasets can be extracted.

A full set of study data, which Pfizer is providing, is extremely valuable because it enables scientists to evaluate the electrical activity in the heart before and after study participants took the drug and compare that data to study subjects who received a placebo or a control drug that is known to prolong the repolarization process.

Earlier this year, URMC announced that it was collaborating with the U.S. Food and Drug Administration (FDA) to develop a national repository of data that will aid academic and industry researchers studying the electrical activity of the heart. The resulting database, called the Telemetric and Holter ECG Warehouse (THEW), consists of a digital catalogue of continuous recordings from both cardiac patients and healthy individuals and is available to academic researchers, pharmaceutical companies, contract research organizations, device manufacturers, and other interested parties.

The Pfizer data, in compliance with international privacy laws, has been fully anonymized, or stripped of any information that would enable individual patients to be identified. Additionally, the THEW was designed in order to comply with ethics and patient privacy laws; all data in the warehouse have been de-identified and the system is fully compliant with federal privac
'/>"/>

Contact: Mark Michaud
mark_michaud@urmc.rochester.edu
585-273-4790
University of Rochester Medical Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. AUDIO from Medialink and Pfizer: November is National Epilepsy Awareness Month
2. Senator Gordon Smith Joins Virginia Garcia Memorial Health Center and Pfizer to Honor a Community Caregiver
3. CHASS Center, Inc. and Pfizer Honor Health Care Heroes
4. AUDIO from Medialink and Pfizer: Community Health Centers Celebrated for Making Quality Care Available to Uninsured Americans
5. New York-Based Sanders Law Firm Files Five Product Liability Lawsuits Against Pfizer on Behalf of Chantix™ Plaintiffs
6. Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris
7. Pfizer Launches Think Science Now
8. Pfizer to Pay $975,000 for Alleged Clean Air Violations at Connecticut Facility
9. Ranbaxy and Pfizer Settle Lipitor Litigation Worldwide
10. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
11. Pfizers work on penicillin for World War II becomes a National Historic Chemical Landmark

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/10/2009)... WAVE (Whole-Body Advanced Vibration Exercise),...g edge vibration exercise technology into South Am...All three of WAVE’s revolutionary vibration ...lus, are now available in South America. , ...E (Whole-Body Advanced Vibration Exercise), a Nort...
(Date:11/10/2009)...rsity Rollins School of Public Health researchers ...merican Public Health Association,s annual meeting...compliance with national recommendations that a ph...es of their arrival to the Emergency Department (E... from Emory scientists are highlighted below. , ...
(Date:11/9/2009)...reness Month Highlighted During Broadcast ,, W...Cancer Alliance (LCA) announced that LCA staff, ad... the New York Stock Exchange(TM) (NYSE) tomorrow a...ewscom.com/cgi-bin/prnh/20081016/LCALOGO ) ,, ...NY advocate, Richard Heimler will mark the end of ...
(Date:11/9/2009)... 9 The Churchill Centre today an...ership to J.W. "Bill" Marriott for his lifelong co...e free market practices and fostering an open and ...will receive his award at a ceremony and dinner on...Seasons Hotel. ,, "This is a testament to how ...
(Date:11/9/2009)...women almost equally, study finds, , , ... clot-dissolving drug Plavix (clopidogrel) works a...ajor clinical trials has found. , "After this s...th men and women with this very important drug," s...lar thrombosis at New York University Langone Medi...
Breaking Medicine News(10 mins):Health News:WAVE's Revolutionary Whole-Body Advanced Vibration Exercise Is Now Available in South America 2Health News:Some chest pain patients wait longer than 10 minutes to see ER physician 2Health News:Lung Cancer Alliance Staff and Advocates to Ring Closing Bell of New York Stock Exchange(TM) 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3
...have linked vancomycin to an abnormal decrease in ...topenia//. If accompanied by uncontrollable bleedi...suspected of having thrombocytopenia, or low blood...he researchers obtained clinical information on 29...
...ice warm cup of green tea has long been touted for...But now researchers have found// that a component ...nhibitor, could slow the spread of human prostate ...-2 inhibitor celecoxib, administered with a green ...
...has found that the primary care providers who trea...fer either HIV testing or safer sex advice to them...g the Hispanics has risen considerably. The ...Ps) — including doctors, nurse practitioners and p...
...ins study has proven false established medical pra...reat hepatitis B liver infections was safe to use/...ir findings demonstrate that treatment with enteca...ther that has been shown to be active against HIV ...
...hers have uncovered new clues that may explain why...hind the eyes, often causing them to bulge painful...y Feldman. Scientists at UCLA’s Jules Stein ...the Journal of Immunology, their study may deepen ...
...victims of sexual assault seek help, negative soci...s of the crime// , according to a University of Il...d in the March issue of Psychology of Women Quarte...er symptoms. The findings suggest further pu...
Other Medicine News:Health News:Antibiotic Vancomycin May Trigger Dangerously Low Platelet Count 2Health News:Green Tea and COX-2 Inhibitors Combine to Slow Growth of Prostate Cancer 2Health News:Green Tea and COX-2 Inhibitors Combine to Slow Growth of Prostate Cancer 3Health News:HIV Tests Offered to Los Angeles Hispanics Insufficient: Study 2Health News:HIV Tests Offered to Los Angeles Hispanics Insufficient: Study 3Health News:Widely Used Hepatitis B Drug Spurs HIV Drug Resistance 2Health News:Widely Used Hepatitis B Drug Spurs HIV Drug Resistance 3Health News:Study Uncovers Clues for Why Graves’ Disease Attacks the Eye 2Health News:Study Examines Negative Reactions to Sexual Assault Victims 2
(Date:11/9/2009)..., AUSTIN, Texas, Nov. 9 Celli...rs, is collaborating with Tissue Genesis, Inc. to ... derived adult stem cells. SpineSmith acquired th...se (fat) tissue derived stem cell technology in No...this new exclusive agreement allows Celling Techno...
(Date:11/9/2009)..., ST. LOUIS, Nov. 9, 2009 /PRNewswire-FirstCa...nc (NYSE: PFE ) today announced that they have en...izer,s Chesterfield Village Research Center locate...eement, Monsanto will acquire the property from Pf...izer will continue to have operations at Chesterfi...
(Date:11/9/2009)..., PISCATAWAY, N.J., Nov. 9 /PRNewswire-FirstC...ard: MLSS), the recognized leader in computer-cont...t it will be showcasing its patented, award-winnin...ystem) at the Madow Group,s 15th year of TBSE tit... place at the Las Vegas Hilton. ,, The STA S...
Breaking Medicine Technology:Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 3Monsanto to Purchase Chesterfield Village Research Center From Pfizer 2Monsanto to Purchase Chesterfield Village Research Center From Pfizer 3Milestone Scientific to Exhibit at the 15th Anniversary of TBSE (The Best Seminar Ever) in Las Vegas 2Hard to Treat Diseases Inc 28HTDS 29 Reports on Ribavirin Research as Potential Treatment for MS 52558 1Hard to Treat Diseases Inc 28HTDS 29 Reports on Ribavirin Research as Potential Treatment for MS 52558 2Hard to Treat Diseases Inc 28HTDS 29 Reports on Ribavirin Research as Potential Treatment for MS 52558 3Video of EpiDerm Skin Irritation Test 28SIT 29 Method Now Available 13170 1Video of EpiDerm Skin Irritation Test 28SIT 29 Method Now Available 13170 2Twinlabs 28R 29 Mobile Beach Bash Heats Up After a Successful Kick Off of the 2009 RateYourAbs com Contest 52549 1Twinlabs 28R 29 Mobile Beach Bash Heats Up After a Successful Kick Off of the 2009 RateYourAbs com Contest 52549 2
....Y.--(BUSINESS WIRE)--Jun 18, 2007 - Advanced Vira...iopharmaceutical,company, announced today that pre...ological study show topical treatment with AVR118,...ammation and,redness associated with surgical inci...open label dermatological study is evaluating the,...
...an 70 abstracts highlight VELCADE efficacy in broa...-, CAMBRIDGE, Mass., June 19, 2007 /PRNewswire-Fir...announced that data for,VELCADE, the market leadin...or patients with previously treated multiple myelo...ional Myeloma,Workshop (IMW) in Kos, Greece, June ...
Other Medicine Technology:Advanced Viral Research Corp. Announces Positive Preliminary,Findings from Ongoing Phase II Dermatological Study 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 2Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 3Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 4Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 5Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 6Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 7Velcade (bortezomib) for Injection Survival Data in Front-Line,Multiple Myeloma Patients to be Featured at 11th International,Myeloma Workshop 8
MD Series Threaded Bone Dowels
CORNERSTONE SELECT Fibula Wedge
Coreograft PLIF Allograft System
Corlok Lumbar Allograft System
Medicine Products: